A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein

Y Li, Y Wan, P Liu, J Zhao, G Lu, J Qi, Q Wang, X Lu… - Cell research, 2015 - nature.com
Abstract The newly-emerging Middle East respiratory syndrome coronavirus (MERS-CoV)
can cause severe and fatal acute respiratory disease in humans. Despite global efforts, the …

Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27

X Yu, S Zhang, L Jiang, Y Cui, D Li, D Wang, N Wang… - Scientific reports, 2015 - nature.com
Abstract The recently reported Middle East respiratory syndrome coronavirus (MERS-CoV)
causes severe respiratory illness in humans with an approximately 30% mortality rate. The …

A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike …

L Du, G Zhao, Y Yang, H Qiu, L Wang, Z Kou… - Journal of …, 2014 - Am Soc Microbiol
Prophylactic and therapeutic strategies are urgently needed to combat infections caused by
the newly emerged Middle East respiratory syndrome coronavirus (MERS-CoV). Here, we …

Advances in MERS-CoV vaccines and therapeutics based on the receptor-binding domain

Y Zhou, Y Yang, J Huang, S Jiang, L Du - Viruses, 2019 - mdpi.com
Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) is an infectious virus
that was first reported in 2012. The MERS-CoV genome encodes four major structural …

A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses …

L Du, Z Kou, C Ma, X Tao, L Wang, G Zhao, Y Chen… - PloS one, 2013 - journals.plos.org
An emerging respiratory infectious disease with high mortality, Middle East respiratory
syndrome (MERS), is caused by a novel coronavirus (MERS-CoV). It was first reported in …

Structural definition of a neutralization-sensitive epitope on the MERS-CoV S1-NTD

N Wang, O Rosen, L Wang, HL Turner, LJ Stevens… - Cell reports, 2019 - cell.com
Middle East respiratory syndrome coronavirus (MERS-CoV) emerged into the human
population in 2012 and has caused substantial morbidity and mortality. Potently neutralizing …

Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein

I Widjaja, C Wang, R van Haperen… - Emerging microbes & …, 2019 - Taylor & Francis
ABSTRACT The Middle-East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic
virus that causes severe and often fatal respiratory disease in humans. Efforts to develop …

Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on the Middle East respiratory syndrome coronavirus spike glycoprotein to avoid …

L Wang, W Shi, JD Chappell, MG Joyce… - Journal of …, 2018 - Am Soc Microbiol
Middle East respiratory syndrome coronavirus (MERS-CoV) causes a highly lethal
pulmonary infection with∼ 35% mortality. The potential for a future pandemic originating …

Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein

H Zhou, Y Chen, S Zhang, P Niu, K Qin, W Jia… - Nature …, 2019 - nature.com
Most neutralizing antibodies against Middle East respiratory syndrome coronavirus (MERS-
CoV) target the receptor-binding domain (RBD) of the spike glycoprotein and block its …

Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus

Y Chen, KR Rajashankar, Y Yang… - Journal of …, 2013 - Am Soc Microbiol
ABSTRACT The newly emerged Middle East respiratory syndrome coronavirus (MERS-
CoV) has infected at least 77 people, with a fatality rate of more than 50%. Alarmingly, the …